Literature DB >> 25505244

Site-directed mutagenesis reveals regions implicated in the stability and fiber formation of human λ3r light chains.

Miryam I Villalba1, Juan C Canul-Tec1, Oscar D Luna-Martínez1, Rosalba Sánchez-Alcalá1, Timoteo Olamendi-Portugal1, Enrique Rudiño-Piñera1, Sonia Rojas1, Rosana Sánchez-López2, Daniel A Fernández-Velasco3, Baltazar Becerril4.   

Abstract

Light chain amyloidosis (AL) is a disease that affects vital organs by the fibrillar aggregation of monoclonal light chains. λ3r germ line is significantly implicated in this disease. In this work, we contrasted the thermodynamic stability and aggregation propensity of 3mJL2 (nonamyloidogenic) and 3rJL2 (amyloidogenic) λ3 germ lines. Because of an inherent limitation (extremely low expression), Cys at position 34 of the 3r germ line was replaced by Tyr reaching a good expression yield. A second substitution (W91A) was introduced in 3r to obtain a better template to incorporate additional mutations. Although the single mutant (C34Y) was not fibrillogenic, the second mutation located at CDR3 (W91A) induced fibrillogenesis. We propose, for the first time, that CDR3 (position 91) affects the stability and fiber formation of human λ3r light chains. Using the double mutant (3rJL2/YA) as template, other variants were constructed to evaluate the importance of those substitutions into the stability and aggregation propensity of λ3 light chains. A change in position 7 (P7D) boosted 3rJL2/YA fibrillogenic properties. Modification of position 48 (I48M) partially reverted 3rJL2/YA fibril aggregation. Finally, changes at positions 8 (P8S) or 40 (P40S) completely reverted fibril formation. These results confirm the influential roles of N-terminal region (positions 7 and 8) and the loop 40-60 (positions 40 and 48) on AL. X-ray crystallography revealed that the three-dimensional topology of the single and double λ3r mutants was not significantly altered. This mutagenic approach helped to identify key regions implicated in λ3 AL.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Amyloid; Antibody; Fibril; Mutagenesis in Vitro; Thermodynamics

Mesh:

Substances:

Year:  2014        PMID: 25505244      PMCID: PMC4317031          DOI: 10.1074/jbc.M114.629550

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Protein misfolding and disease; protein refolding and therapy.

Authors:  C Soto
Journal:  FEBS Lett       Date:  2001-06-08       Impact factor: 4.124

2.  Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins.

Authors:  Jonathan S Wall; Vibha Gupta; Matthew Wilkerson; Maria Schell; Remy Loris; Paul Adams; Alan Solomon; Fred Stevens; Chris Dealwis
Journal:  J Mol Recognit       Date:  2004 Jul-Aug       Impact factor: 2.137

3.  Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain.

Authors:  K E Olsen; K Sletten; P Westermark
Journal:  Biochem Biophys Res Commun       Date:  1998-04-28       Impact factor: 3.575

Review 4.  Therapeutic strategies for human amyloid diseases.

Authors:  James C Sacchettini; Jeffery W Kelly
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

5.  Pitfalls of molecular replacement: the structure determination of an immunoglobulin light-chain dimer.

Authors:  D B Huang; C Ainsworth; A Solomon; M Schiffer
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1996-11-01

6.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

Authors:  J D Marks; H R Hoogenboom; T P Bonnert; J McCafferty; A D Griffiths; G Winter
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

Review 7.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

8.  AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides.

Authors:  Oscar Conchillo-Solé; Natalia S de Groot; Francesc X Avilés; Josep Vendrell; Xavier Daura; Salvador Ventura
Journal:  BMC Bioinformatics       Date:  2007-02-27       Impact factor: 3.169

9.  Biochemical and aggregation analysis of Bence Jones proteins from different light chain diseases.

Authors:  Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Amyloid       Date:  2008-03       Impact factor: 7.141

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  5 in total

1.  Single amino acid substitution in LC-CDR1 induces Russell body phenotype that attenuates cellular protein synthesis through eIF2α phosphorylation and thereby downregulates IgG secretion despite operational secretory pathway traffic.

Authors:  Haruki Hasegawa; Ann Hsu; Christine E Tinberg; Karen E Siegler; Aaron A Nazarian; Mei-Mei Tsai
Journal:  MAbs       Date:  2017-04-05       Impact factor: 5.857

2.  Structure and energetic basis of overrepresented λ light chain in systemic light chain amyloidosis patients.

Authors:  Jun Zhao; Baohong Zhang; Jianwei Zhu; Ruth Nussinov; Buyong Ma
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-12-12       Impact factor: 5.187

3.  Epigallocatechin-3-gallate preferentially induces aggregation of amyloidogenic immunoglobulin light chains.

Authors:  Manuel Hora; Martin Carballo-Pacheco; Benedikt Weber; Vanessa K Morris; Antje Wittkopf; Johannes Buchner; Birgit Strodel; Bernd Reif
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

4.  Different Dynamics in 6aJL2 Proteins Associated with AL Amyloidosis, a Conformational Disease.

Authors:  Roberto Maya-Martinez; Leidys French-Pacheco; Gilberto Valdés-García; Nina Pastor; Carlos Amero
Journal:  Int J Mol Sci       Date:  2019-08-21       Impact factor: 5.923

5.  Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity.

Authors:  Luca Oberti; Paola Rognoni; Alberto Barbiroli; Francesca Lavatelli; Rosaria Russo; Martina Maritan; Giovanni Palladini; Martino Bolognesi; Giampaolo Merlini; Stefano Ricagno
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.